Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Surgical management of fecal incontinence wikipedia , lookup
Gastrointestinal tract wikipedia , lookup
Fecal incontinence wikipedia , lookup
Anti-obesity medication wikipedia , lookup
Gastric bypass surgery wikipedia , lookup
Inflammatory bowel disease wikipedia , lookup
Name /bks_53161_deglins_md_disk/polyethyleneglycol 03/14/2014 08:17AM 1 polyethylene glycol (po-lee-eth-e-leen glye-kole) ClearLax, GlycoLax, Lax-a-Day, MiraLax, Relaxa, RestoraLax Classification Therapeutic: laxatives Pharmacologic: osmotics Pregnancy Category C PegaLax, PolyLax, Plate # 0-Composite pg 1 # 1 Interactions Drug-Drug: None significant. PDF Page #1 Route/Dosage PO (Adults): 17 g (heaping tablespoon) in 8 oz of water; may be used for up to 2 wk. PO (Children ⬎6 mo): 0.5– 1.5 g/kg daily, titrate to effect (maximum: 17 g/day). NURSING IMPLICATIONS Assessment ● Assess patient for abdominal distention, presence of bowel sounds, and usual pat- tern of bowel function. Indications ● Assess color, consistency, and amount of stool produced. Treatment of occasional constipation. Potential Nursing Diagnoses Action Constipation (Indications) Diarrhea (Side Effects) Polyethylene glycol (PEG) in solution acts as an osmotic agent, drawing water into the lumen of the GI tract. Therapeutic Effects: Evacuation of the GI tract without water or electrolyte imbalance. Implementation ● Do not confuse Miralax (polyethylene glycol) with Mirapex (pramipex- ole). Pharmacokinetics Absorption: Nonabsorbable. Distribution: Unknown. Metabolism and Excretion: Excreted in fecal contents. Half-life: Unknown. ● PO: Dissolve powder in 8 oz of water prior to administration. Patient/Family Teaching ● Inform patient that 2– 4 days may be required to produce a bowel movement. PEG TIME/ACTION PROFILE (bowel movement) ROUTE ONSET PEAK DURATION PO unknown 1–3 days unknown Contraindications/Precautions Contraindicated in: GI obstruction; Gastric retention; Toxic colitis; Megacolon; Bowel perforation. should not be used for more than 2 wk. Prolonged, frequent, or excessive use may result in electrolyte imbalance and laxative dependence. ● Advise patient to notify health care professional if unusual cramps, bloating, or diarrhea occurs. Evaluation/Desired Outcomes ● A soft, formed bowel movement. Why was this drug prescribed for your patient? Use Cautiously in: Abdominal pain of uncertain cause, particularly if accompanied by fever; OB, Pedi: Safety not established. Adverse Reactions/Side Effects Derm: urticaria. GI: abdominal bloating, cramping, flatulence, nausea. ⫽ Canadian drug name. ⫽ Genetic Implication. CAPITALS indicate life-threatening, underlines indicate most frequent. Strikethrough ⫽ Discontinued.